06 . 01 . 2014

IMD recognises Xeltis as the promising Therapeutical MedTech startup of 2014. Every year IMD searches for promising startups to work with their MBA and EMBA students. For 2014, IMD has announced that Xeltis is their annual choice from the MedTech industry from over 100 applicants to collaborate with IMD participants. This IMD recognition of Xeltis as a promising startup for its annual Startup Competition is another indication that Xeltis is seen by the industry as a company definitely to watch.

Go back